Annual progress of transcatheter mitral valve intervention in 2022
- VernacularTitle:2022年经导管二尖瓣介入治疗年度进展
- Author:
Lin BAI
1
;
Fei CHEN
1
;
Zhengang ZHAO
1
;
Yong PENG
1
;
Yuan FENG
1
;
Mao CHEN
1
Author Information
1. Department of Cardiology, West China Hospital, Sichuan University, Chengdu, 610041, P. R. China
- Publication Type:Journal Article
- Keywords:
Mitral regurgitation;
transcatheter mitral valve intervention;
transcatheter mitral valve repair;
transcatheter edge-to-edge repair;
transcatheter mitral valve replacement
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2023;30(06):805-811
- CountryChina
- Language:Chinese
-
Abstract:
Mitral regurgitation is the most common heart valvular disease at present. In the past, mitral regurgitation was mainly treated by surgical mitral valve repair or replacement. However, with the progress of transcatheter interventional techniques and instruments in recent years, transcatheter mitral valve interventional therapy has gradually shown its advantages and benefited patients. The purpose of this article is to review the progress of transcatheter mitral valve intervention in this year, and to provide prospects for the future of transcatheter mitral valve treatment.
